The association between psoriasis and dyslipidaemia: a systematic review
- PMID: 23106411
- DOI: 10.1111/bjd.12101
The association between psoriasis and dyslipidaemia: a systematic review
Abstract
Psoriasis may be associated with dyslipidaemia, a known risk factor for cardiovascular disease. This systematic review aims to synthesize evidence for the association between psoriasis and dyslipidaemia. Through a systematic search using MEDLINE, Embase and the Cochrane Central Register, from 1 January 1980 to 1 January 2012, we identified 25 observational studies that met the inclusion criteria. These 25 studies included over 2·4 million participants, among whom 265,512 were patients with psoriasis. Twenty studies (80%) reported that psoriasis was significantly associated with dyslipidaemia, with odds ratios (ORs) for dyslipidaemia ranging from 1·04 to 5·55 in 238,385 patients with psoriasis, from a population of 2,340,605 participants. Specifically, four studies defining dyslipidaemia as triglyceride levels ≥ 150 mg dL reported significantly increased ORs of 1·20-4·98 for hypertriglyceridaemia in psoriasis. Three studies found that patients with psoriasis presented with significantly increased ORs (1·36-1·77) for high-density lipoprotein cholesterol levels < 40 mg dL , and two studies found hyperlipoproteinaemia to be significantly elevated in patients with psoriasis (ORs 1·55 and 2·09). One cohort study found a significantly higher incidence of hyperlipidaemia among patients with psoriasis (hazard ratio 1·17; 95% confidence interval 1·11-1·23). Among studies that assessed the severity of psoriasis, in 2662 patients with mild psoriasis and 810 patients with severe psoriasis, higher odds of dyslipidaemia were seen in patients with severe psoriasis. Five of the 25 studies (20%) in our review did not show any significant relationship between psoriasis and dyslipidaemia. This systematic review found that psoriasis was significantly associated with greater odds and incidence of dyslipidaemia. Greater psoriasis severity appeared to be associated with higher prevalence of dyslipidaemia.
© 2012 The Authors. BJD © 2012 British Association of Dermatologists.
Similar articles
-
Psoriasis and dyslipidaemia: a population-based study.Acta Derm Venereol. 2008;88(6):561-5. doi: 10.2340/00015555-0510. Acta Derm Venereol. 2008. PMID: 19002339
-
Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases.Ann Dermatol Venereol. 2016 Apr;143(4):264-74. doi: 10.1016/j.annder.2015.06.024. Epub 2016 Mar 8. Ann Dermatol Venereol. 2016. PMID: 26969480
-
Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug. Report No.: 14-05204-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug. Report No.: 14-05204-EF-1. PMID: 27559550 Free Books & Documents. Review.
-
The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies.J Hypertens. 2013 Mar;31(3):433-42; discussion 442-3. doi: 10.1097/HJH.0b013e32835bcce1. J Hypertens. 2013. PMID: 23249828 Review.
-
Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies.J Am Acad Dermatol. 2013 Apr;68(4):654-662. doi: 10.1016/j.jaad.2012.08.015. Epub 2013 Jan 27. J Am Acad Dermatol. 2013. PMID: 23360868 Review.
Cited by
-
Association Between Non-HDL to HDL Cholesterol Ratio (NHHR) and Psoriasis in Adults: A Cross-Sectional Study Using 2009-2014 Data.Clin Cosmet Investig Dermatol. 2024 Nov 9;17:2523-2531. doi: 10.2147/CCID.S492053. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 39544258 Free PMC article.
-
Early Cerebral Microvasculature Impairment and Increased Body Mass Index in Patients with Psoriasis.Biomedicines. 2024 Jul 23;12(8):1627. doi: 10.3390/biomedicines12081627. Biomedicines. 2024. PMID: 39200092 Free PMC article.
-
Assessing the genetic associations between plasma lipidomic profiles and psoriasis vulgaris.Arch Dermatol Res. 2024 Jul 29;316(8):494. doi: 10.1007/s00403-024-03217-4. Arch Dermatol Res. 2024. PMID: 39073618
-
Managing the Patient with Psoriasis and Metabolic Comorbidities.Am J Clin Dermatol. 2024 Jul;25(4):527-540. doi: 10.1007/s40257-024-00857-0. Epub 2024 May 15. Am J Clin Dermatol. 2024. PMID: 38748391 Free PMC article. Review.
-
The Role of Epigenetic Factors in the Pathogenesis of Psoriasis.Int J Mol Sci. 2024 Mar 29;25(7):3831. doi: 10.3390/ijms25073831. Int J Mol Sci. 2024. PMID: 38612637 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous